Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer

Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer

BOULDER -- Biodesix Inc. and London-based Immodulon Therapeutics Limited, announced they have entered into a biomarker research collaboration. The partnership will focus on the analysis of... Read More

Tuesday July 30, 2019 0 comments Tags: Boulder, Biodesix, Immodulon, David Brunel

Biodesix partners with Thermo Fisher Scientific on blood-based cancer test

Biodesix partners with Thermo Fisher Scientific on blood-based cancer test

BOULDER -- Biodesix, Inc , a leader in blood-based lung cancer diagnostic solutions, announced it has entered into an agreement with Thermo Fisher Scientific designed to bring a blood-based... Read More

Wednesday July 10, 2019 0 comments Tags: Boulder, Biodesix, Thermo Fisher Scientific, David Brunel

CBSA, Sen. Bennet host FDA commissioner Robert Califf at Life Science Roundtable

CBSA, Sen. Bennet host FDA commissioner Robert Califf at Life Science Roundtable

DENVER -- Colorado BioScience Association (CBSA) and Colorado Senator Michael Bennet hosted close to 50 Colorado life science industry leaders to meet FDA Commissioner Dr. Robert Califf as... Read More

Monday April 4, 2016 0 comments Tags: Denver, CBSA, CBSA Life Sciences Industry Roundtable, Sen. Michael Bennet, April Giles, David Brunel, FDA, Dr. Robert Califf

BioWest 2014 offers insight on creating healthier workforce, getting products to market

BioWest 2014 offers insight on creating healthier workforce, getting products to market

Biannual conference and expo highlights life science industry progress, challenges By Steve Porter InnovatioNews DENVER - If the nation's health care system can be shaken up... Read More

By: Steve Thursday September 11, 2014 0 comments Tags: April Giles, Bill Aldrich, BioWest 2014, Byron Hewett, David Brunel, Denver, James Hill, Jandel Allen-Davis, Len Tacconi, Margaret Hamburg, Russell Slifer

Biodesix closes on $20M debt financing with Capital Royalty Partners

Biodesix closes on $20M debt financing with Capital Royalty Partners

BOULDER - Biodesix Inc. , a fully-integrated molecular diagnostic company focused on personalized medicine, announced it has closed on a structured debt financing with Houston-based Capital... Read More

By: InnovatioNews Monday January 13, 2014 0 comments Tags: Biodesix, Boulder, Charles Tate, David Brunel, VeriStrat